Tamoxifen enhances stemness and promotes metastasis of ERα36(+) breast cancer by upregulating ALDH1A1 in cancer cells

The 66 kDa estrogen receptor alpha (ERα66) is the main molecular target for endocrine therapy such as tamoxifen treatment. However, many patients develop resistance with unclear mechanisms. In a large cohort study of breast cancer patients who underwent surgery followed by tamoxifen treatment, we de...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiang, Jiang, Jun, Ying, Guoguang, Xie, Xiao-Qing, Zhang, Xia, Xu, Wei, Zhang, Xuemin, Song, Erwei, Bu, Hong, Ping, Yi-Fang, Yao, Xiao-Hong, Wang, Bin, Xu, Shilei, Yan, Ze-Xuan, Tai, Yanhong, Hu, Baoquan, Qi, Xiaowei, Wang, Yan-Xia, He, Zhi-Cheng, Wang, Yan, Wang, Ji Ming, Cui, You-Hong, Chen, Feng, Meng, Kun, Wang, Zhaoyi, Bian, Xiu-Wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835774/
https://www.ncbi.nlm.nih.gov/pubmed/29393296
http://dx.doi.org/10.1038/cr.2018.15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835774/
https://www.ncbi.nlm.nih.gov/pubmed/29393296
http://dx.doi.org/10.1038/cr.2018.15

Ejemplares similares